Real-world burden of disease, treatment, and healthcare resource utilization in acromegaly: a quantitative survey of patient experiences [PDF]
Background Acromegaly is a rare endocrine disease caused by excessive growth hormone (GH) secretion typically due to a pituitary adenoma. Patients ineligible for or with an inadequate response to surgery and/or radiotherapy often require pharmacotherapy ...
Maxwell Koobatian +4 more
doaj +2 more sources
Healthcare utilization and costs among patients with acromegaly in the United States [PDF]
Aim: Recent evidence regarding the healthcare resource utilization (HCRU) and associated costs of acromegaly is limited. Materials & methods: This retrospective, cross-sectional administrative claims analysis (IQVIA Pharmetrics Plus) identified ...
Tiffany P Quock +8 more
doaj +2 more sources
Clinical and economic burden among older adults with acromegaly in the United States [PDF]
Aim: To compare healthcare resource utilization (HCRU) and costs between older adults with and without acromegaly. Materials & methods: Using 2017–2022 100% Medicare Research Identifiable Files, we identified beneficiaries (≥65 years) with prevalent ...
Tiffany P Quock +7 more
doaj +2 more sources
Association of Epicardial Adipose Tissue Thickness with Cardiovascular Risk in Acromegaly
Objective: Acromegaly is a rare disease associated with increased mortality. Reports on coronary artery disease in acromegaly are controversial. This study aimed to investigate the possible association of epicardial adipose tissue thickness with ...
Bulent CAN +3 more
doaj +1 more source
Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine [PDF]
The clinical characteristics and prognoses of acromegaly vary among patients. Assessment of current and novel predictors can lead to multilevel categorization of patients, allowing integration into new clinical guidelines and a reduction in the increased
Kyungwon Kim +2 more
doaj +1 more source
Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) are essential to normal growth, metabolism, and body composition, but in acromegaly, excesses of these hormones strikingly alter them.
Pamela U. Freda
doaj +1 more source
Old Wine in a New Bottle: Acromegaly Presenting as Diabetic Ketoacidosis [PDF]
Acromegaly is a rare disease characterised by chronic excess of Growth Hormone (GH) levels. Insulin signalling is impaired, gluconeogenesis is excess and peripheral insulin resistance is increased in acromegaly causing hyperglycaemia and diabetes ...
Sowrabha Bhat +3 more
doaj +1 more source
Prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region [PDF]
Aim. Assessment of prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region. Materials and methods. Cardiorespiratory monitoring was executed to 55 patients with acromegaly (18 men and 37 women): 27 patients
Yu A Kovaleva +4 more
doaj +1 more source
Ageing genetic signature of hypersomatotropism
Acromegaly is a pathological condition that is caused by over-secretion of growth hormone (GH) and develops primarily from a pituitary adenoma. Excess GH exposure over a prolonged period of time leads to a wide range of systemic manifestations and ...
Abdalla Elbialy
doaj +1 more source
Presence of cerebral microbleeds is associated with cognitive decline in acromegaly
BackgroundCognitive decline in acromegaly has gained increasing attention. Cerebral microbleeds (CMBs) as radiographic markers for microvascular injury have been linked to various types of cognitive decline. However, the association between CMB formation
Zhengxing Xie +7 more
doaj +1 more source

